Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 5378
118th Congress(2023-2024)
Lower Costs, More Transparency Act
Active
Active
Passed House on Dec 11, 2023
Overview
Text
Introduced
Sep 8, 2023
Latest Action
Dec 11, 2023
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5378
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Cathy McMorris Rodgers
Washington
Republican
Jason Smith
Missouri
Democrat
Frank Pallone
New Jersey
Republican
Virginia Foxx
North Carolina
House Votes (1)
Senate Votes (0)
checkPassed on December 12, 2023
Question
On Motion to Suspend the Rules and Pass, as Amended
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
708
House Roll Call Votes
Summary

Lower Costs, More Transparency Act

This bill requires health care providers and insurers to disclose certain information about health care costs. It also establishes requirements for certain payment methodologies under Medicare and Medicaid and extends several public health programs.

For example, the bill provides statutory authority for regulations that require hospitals to annually publish their prices and related information, including the discounted cash price and negotiated charges. The bill also specifically extends these requirements to clinical laboratories, imaging service providers, and ambulatory surgical centers that participate in Medicare. Additionally, pharmacy benefit managers (PBMs) must semiannually report to health plan sponsors on the number and types of claims for covered drugs, including whether the drugs were brand-name or generic drugs and associated costs. Contracts with PBMs for employer-sponsored health plans must also allow health plan fiduciaries to audit certain claims and cost information without undue restrictions.

In addition, the bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid. It also requires Medicare payments for certain drug administration services at off-campus hospital outpatient departments to be the same as that for other provider settings (i.e., physician offices).

The bill provides funds for the Department of Health and Human Services, the Department of Treasury, and the Department of Labor to implement and enforce the bill's requirements.

Finally, the bill extends several public health programs, including the Teaching Health Center Graduate Medical Education Program (through FY2030) and the National Health Service Corps (through December 31, 2025).

Text (2)
Engrossed in House
December 11, 2023
Introduced in House
September 8, 2023
Related Bills (10)
Jul 25, 2023
Introduced in House
1
Sponsorship
House Bill 4883
Medicare Common Ownership Transparency Act of 2023
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Jul 13, 2023
Introduced in Senate
1
Sponsorship
Senate Bill 2308
Community Health Care Reauthorization Act
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Jul 11, 2023
Introduced in House
3
Sponsorship
House Bill 4527
Health DATA Act of 2023
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Jul 10, 2023
Introduced in House
2
Sponsorship
House Bill 4508
Hidden Fee Disclosure Act of 2023
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Jun 07, 2023
Introduced in Senate
4
Sponsorship
Senate Bill 1855
Special Diabetes Program Reauthorization Act of 2023
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Jun 06, 2023
Introduced in House
2
Sponsorship
House Bill 3839
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
May 15, 2023
Introduced in House
5
Sponsorship
House Bill 3284
Providers and Payers COMPETE Act
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
May 11, 2023
Introduced in House
2
Sponsorship
House Bill 3237
To amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department.
Introduced
Type
Identical Bill
Identical Bill
A bill that is word-for-word identical to another bill. Bills are characterized as identical to each other at the introduced stage only, even though a later (e.g., reported or passed) version of a bill might meet the same criteria for text similarity. Companion measures, procedurally-related measures, and legislation with text similarities are other related bill types.
Identified By
CRS
Apr 18, 2023
Introduced in House
129
Sponsorship
House Bill 2665
Supporting Safety Net Hospitals Act
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Mar 14, 2023
Introduced in Senate
4
Sponsorship
Senate Bill 775
Increasing Transparency in Generic Drug Applications Act
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Actions (11)
12/11/2023
Motion to reconsider laid on the table Agreed to without objection.
12/11/2023
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 320 - 71, 1 Present (Roll no. 708). (text: CR H6762-6785)
12/11/2023
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 320 - 71, 1 Present (Roll no. 708).(text: CR H6762-6785)
12/11/2023
Considered as unfinished business. (consideration: CR H6801-6802)
12/11/2023
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
12/11/2023
DEBATE - The House proceeded with forty minutes of debate on H.R. 5378.
12/11/2023
Considered under suspension of the rules. (consideration: CR H6762-6789)
12/11/2023
Mrs. Rodgers (WA) moved to suspend the rules and pass the bill, as amended.
09/15/2023
Referred to the Subcommittee on Health.
09/08/2023
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
09/08/2023
Introduced in House
Graphics
H.R.5378 118 Lower Costs More Transparency Act
How Graphics are created
Public Record
Record Updated
Feb 14, 2024 4:56:05 PM
Copyright © 2024 Civic Bits LLC
Privacy Policy
Terms of Service
What's New
About